Imurel

Azathioprine, the active ingredient in Imurel, is an immunosuppressant presented as an oral tablet for oral use. It is employed to reduce immune system activity in conditions such as organ transplantation, rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus. GNH USA supplies Imurel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, pharmacies and clinics worldwide.

Azathioprine is used to modulate immune activity in several chronic inflammatory and autoimmune conditions. - Organ transplantation: helps prevent graft rejection by suppressing lymphocyte proliferation. - Rheumatoid arthritis: reduces joint inflammation and disease progression. - Inflammatory bowel disease: controls symptoms of Crohn's disease and ulcerative colitis. - Systemic lupus erythematosus: diminishes systemic immune activation and organ damage.

Azathioprine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting: gastrointestinal discomfort is frequently reported. - Leukopenia: reduced white blood cell count, increasing infection risk. - Elevated liver enzymes: mild hepatic irritation detectable in blood tests. - Rash or mild skin irritation: occasional dermatologic response.

Serious or Rare Side Effects: - Severe bone marrow suppression: pancytopenia requiring medical intervention. - Hepatotoxicity: significant liver injury manifesting as jaundice or hepatitis. - Increased risk of opportunistic infections: due to profound immunosuppression. - Possible malignancy risk: long‑term use may be associated with certain cancers.

Before initiating therapy with Azathioprine, several safety considerations are recommended. - Baseline testing: obtain complete blood count and liver function tests prior to treatment. - Monitoring: perform regular CBC and hepatic panels to detect toxicity early. - Infection vigilance: advise patients to report signs of infection promptly. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Azathioprine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Allopurinol or febuxostat: may cause severe bone marrow suppression. - Thiopurine methyltransferase (TPMT) inhibitors: increase risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Live vaccines: increased risk of infection; avoid administration. - Antacids containing magnesium or aluminum: may reduce absorption. - Ribavirin: potential additive hematologic toxicity. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase renal risk when combined.